Faraz Ali Insider Profile
11 Followers
Faraz Ali, CEO, Director at Tenaya Therapeutics, holds 417.78K shares in Tenaya Therapeutics (Ticker: TNYA), holds ― shares in RegenXBio (Ticker: RGNX). Most recently, Faraz Ali Sold ― shares of Tenaya Therapeutics on Aug 17, 2026 for an estimated value of $15.56K.
Profitable Transactions
7 out of 10 Profitable Transactions
Average Return
+9.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Faraz Ali holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Feb 16, 2024 - Feb 16, 2025
Return:+81.00%
The most profitable trade made by Faraz Ali
Faraz Ali's Trading History
Tenaya Therapeutics
Aug 17, 2026
CEO, Director
Informative Sell
15.56K
$270.72K
RegenXBio
―
Chief Business Officer
―
―
List of latest transactions for each holding click on a transaction to see Faraz Ali's performance on stock
You May Also Like
Faraz Ali insider profile FAQ
What is the percentage of profitable transactions made by Faraz Ali?
The percentage of profitable transactions made by Faraz Ali is 70%.
What is the average return per transaction made by Faraz Ali?
The average return per transaction made by Faraz Ali is 9.60%.
What stocks does Faraz Ali hold?
Faraz Ali holds: TNYA, RGNX stocks.
What was Faraz Ali’s latest transaction?
Faraz Ali latest transaction was an Informative Sell of $15.56K.
What was Faraz Ali's most profitable transaction?
Faraz Ali’s most profitable transaction was an Informative Sell of TNYA stock on February 16, 2024. The return on the trade was 81.00%.
What is Faraz Ali's role in Tenaya Therapeutics?
Faraz Ali's role in Tenaya Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.